ex-vivo autologous CD40 LG gene therapy (Genespire/San Raffaele Telethon Institute)

N/A

Report date: 2025/03/20 16:00:00

Base Information

Drug Nameex-vivo autologous CD40 LG gene therapy (Genespire/San Raffaele Telethon Institute)
Drug Alias Nameex-vivo autologous T-cell gene therapy (Genespire/San Raffaele Telethon Institute)
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionCD40 ligand modulators
TargetsCD40 ligand
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenespire SRL
China Registration ClassN/A

Develop Information

Active CompaniesGenespire SRLThe San Raffaele Telethon Institute For Gene Therapy
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A